Cross-talk between xenobiotic detoxication and other signalling pathways: clinical and toxicological consequences.
about
The brain dopaminergic system as an important center regulating liver cytochrome P450 in the rat.Drug metabolizing enzyme induction pathways in experimental non-alcoholic steatohepatitis.Chimeric mice with humanized liver: tools for the study of drug metabolism, excretion, and toxicityPhenytoin induction of the cyp2c37 gene is mediated by the constitutive androstane receptor.Semen quality in relation to xenohormone and dioxin-like serum activity among Inuits and three European populations.Evolution and function of the NR1I nuclear hormone receptor subfamily (VDR, PXR, and CAR) with respect to metabolism of xenobiotics and endogenous compounds.Prediction of cis-regulatory elements for drug-activated transcription factors in the regulation of drug-metabolising enzymes and drug transporters.Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.Species differences in the hepatic effects of inducers of CYP2B and CYP4A subfamily forms: relationship to rodent liver tumour formation.Effect of prototypical inducers on ligand activated nuclear receptor regulated drug disposition genes in rodent hepatic and intestinal cells.The effect and clinical consequences of hypoxia on cytochrome P450, membrane carrier proteins activity and expression.Nuclear receptors in the cross-talk of drug metabolism and inflammation.The evolution of our understanding of endo-xenobiotic crosstalk and cytochrome P450 regulation and the therapeutic implications.Ochratoxin A induces CYP3A4, 2B6, 3A5, 2C9, 1A1, and CYP1A2 gene expression in primary cultured human hepatocytes: a possible activation of nuclear receptors.
P2860
Q33445762-005D1AA8-7A54-48D7-9344-5E6168C0D058Q34959342-AFB1A078-6A8B-4748-8D2A-7C5B446FA7E6Q35105009-03006C08-8CB1-4825-BB54-22BE3FBBE5F5Q35185572-1C46F854-DC86-4ADD-A2EB-7F875FC7D0CFQ36326648-0D0207C4-6F60-4566-99CE-B6EE222E39C4Q36440873-96ABC698-AC2B-431C-B087-3286538DDD42Q36544912-9FC5FA0A-F31B-4416-935E-83E3DB744EEDQ37121662-9CB51266-AEE1-4005-A52C-7C15B929CC00Q37557621-6C2E732E-85B8-4571-8A05-91E516439FF3Q37728687-AC9A377C-53BF-42D1-840E-4FB3B3C158A0Q37880895-84BFA29F-2FED-4A0F-93BC-F66140652BC4Q38074993-49E9481D-C6BC-4B17-B0EC-9685CC4EEA2AQ38128592-8D24BE83-2560-49D1-A000-39B144AF001BQ42727700-2FD06FC2-A2EC-431E-B7C8-DBBE5F28C2BD
P2860
Cross-talk between xenobiotic detoxication and other signalling pathways: clinical and toxicological consequences.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Cross-talk between xenobiotic ...... nd toxicological consequences.
@ast
Cross-talk between xenobiotic ...... nd toxicological consequences.
@en
type
label
Cross-talk between xenobiotic ...... nd toxicological consequences.
@ast
Cross-talk between xenobiotic ...... nd toxicological consequences.
@en
prefLabel
Cross-talk between xenobiotic ...... nd toxicological consequences.
@ast
Cross-talk between xenobiotic ...... nd toxicological consequences.
@en
P2093
P2860
P1433
P1476
Cross-talk between xenobiotic ...... nd toxicological consequences.
@en
P2093
Drocourt L
Gerbal-Chaloin S
Pascussi JM
Pichard-Garcia L
Vilarem MJ
P2860
P304
P356
10.1080/00498250412331285454
P407
P577
2004-07-01T00:00:00Z